Home / Europe / United Kingdom / Corporate / Equity Capital Markets

Equity Capital Markets

Back to Corporate

Navigating the world of equity capital markets can be complex. Whether you are looking to take your company public, raise capital or simply keep up with the maze of rules and regulations inherent with running a listed company, our highly experienced experts can help you. Our Equity Capital Markets team brings years of experience to support our issuer, investor and adviser clients in all aspects of Equity Capital Markets work across a broad range of sectors including financial services, consumer products, energy, infrastructure, insurance, healthcare & life sciences, real estate, hotels & leisure and technology, media & telecommunications.

The team has a strong track record of acting on numerous IPOs in the UK and overseas, (including Rule 144A offerings in the US), secondary fundraisings, bond issues and public takeovers, as well as advising listed companies generally on their day-to-day activities, such as complying with the Listing Rules, AIM Rules, Disclosure Rules, MAR and Takeover Code, corporate governance matters and employee incentive plans.

Our listed company clients come from around the world, including the UK, US, Europe, India and China, and operate in a broad range of sectors. On the institutional side, we advise a range of sponsors and nomads, as well as brokers and financial advisers.

Law-Now: Capital Markets
Visit Law-Now for legal know-how and commentary
01/01/2020
Highlights of our experience in Equity Capital Markets
Sequoia Economic Infrastructure Income Fund (SEQI) on a £300m placing, open offer and offer for subscription and further £300m share issuance programme. Primary Health Properties plc on its c.£140m...
Advising the Board

Feed

20/06/2023
CMS closes first of a kind BESS Solar Co-location Project Financing
International law firm CMS has advised DIF Capital Partners (DIF) on the project financing of a 720MW co-located solar generation and battery energy storage system (BESS) portfolio in the UK. DIF, together...
08/06/2023
ESG in corporate transactions
ESG factors are now a key consideration in M&A. According to the CMS European M&A study 2023, investors are facing pressures to uphold higher governance standards across all industries and geographical regions as it ensures the efficient running of a business and consumer confidence. It also seems likely that dealmakers want to capitalise on attractive ESG value creation opportunities.  This page brings together practical resources and insight for ESG considerations in a corporate context, from incorporation into M&A deals, good governance or directors’ duties. If there is a topic you’d like to discuss, please get in touch.
14/07/2022
CMS advises AnaCap Financial Partners on investment in Further Underwriting...
International law firm CMS has advised longstanding client AnaCap Financial Partners (“AnaCap”), a leading private equity firm specialising in European Financial, Technology, and related Business...
23/05/2022
CMS advises M&C Saatchi on £310m contested takeover offer
International law firm CMS is advising long-standing client M&C Saatchi plc (“M&C Saatchi”) on its contested takeover which has resulted in a £310m offer from Next Fifteen Communications Group plc...
27/04/2022
Risk Essentials Webinar - Litigation Risk: Key issues when advising your...
When advising the board on how to approach litigation risk, you have to guide them to balance legal and commercial considerations. The merits of your case need to be weighed against wider commercial factors...
31/03/2022
CMS advises Kansai on its participation in a consortium acquiring a 50%...
International law firm CMS has advised The Kansai Electric Power Co., Inc. (“Kansai”) on its participation in a consortium led by Glennmont Partners and comprising other institutional investors from...
30/03/2022
CMS advises on £97m AIM-IPO of Celadon Pharmaceuticals
CMS has advised Vertigrow Technology Limited on reverse acquisition of Summerway Capital plc and on its admission to trading on AIM as Celadon Pharmaceuticals Plc (Celadon), alongside an accompanying...
22/03/2022
CMS advises consortium on acquisition of interest in Ørsted’s 1.2-GW Hornsea...
International law firm CMS has advised a consortium comprised of The Renewables Infrastructure Group and Equitix on its agreement to acquire a 12.5% interest in the Hornsea One Offshore Wind Farm from...
12/01/2022
ECM Round-Up
Welcome to the CMS ECM Round-Up for January 2022.2021 continued to see high levels of equity capital markets activity and the CMS ECM team supported our clients across a range of transactions, ranging...
02/12/2021
CMS advises LondonMetric on £175m placing and retail offer
International law firm CMS has advised LondonMetric Property Plc (LondonMetric), a FTSE 250 REIT, on a £175m placing of new ordinary shares to institutional investors and retail offer to UK retail investors...
28/06/2021
CMS advises clients in relation to AIM IPO and reverse acquisition
International law firm CMS has advised on two equity capital market transactions in recent weeks. CMS acted for Panmure Gordon as nominated adviser and sole broker to Arecor Therapeutics plc in relation...
16/06/2021
CMS secures place in FCA’s regulatory sandbox
International law firm CMS has been chosen by the UK Financial Conduct Authority (FCA) to participate in its 2021 regulatory sandbox (the sandbox). The FCA received 58 applications for the sandbox, with...